Patty Kaewussdangkul InspectorProfile


This InspectorProfile is a report of relevant audit-related information on Patty Kaewussdangkul, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through and lists Patty Kaewussdangkul's 119 inspections in 6 countries: United States, Thailand, Singapore, Hong Kong SAR, India, and Japan.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Patty Kaewussdangkul's inspection information so that you can mitigate investigator-related risks.

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Patty Kaewussdangkul.

Example Report

Patty Kaewussdangkul FDA InspectorProfile Overview Example
Patty Kaewussdangkul FDA InspectorProfile Metrics Example
Patty Kaewussdangkul FDA InspectorProfile Citations Example
Patty Kaewussdangkul FDA InspectorProfile Inspections List
Add To Cart39 of Kaewussdangkul 483s in stock

Product details

  • Patty Kaewussdangkul's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Patty Kaewussdangkul has conducted including:

Note: The EIR and 483 documents are sold separately.

Add To Cart39 of Patty's 483s Available Now.